Prognostic role of D-Dimer and Coagulation parameters in hospitalized COVID-19 patients
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 400
- 试验地点
- 1
- 主要终点
- Clinical recovery of the patient
研究概览
简要总结
The study is prospective and will take place in the Department of General Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur ,Chennai between March 2021 and March 2023 after obtaining ethical clearance. It aims to evaluate the prognostic role of D-Dimer with illness severity. We also aim to observe the coagulation parameters (PT, PTT and INR) in patients with elevated D-Dimer and assess its correlation with complications and outcome. The identification of effective laboratory biomarkers capable of triaging patients with COVID-19 infection is very necessary taking into account the unpredictable course of the disease. Studies have shown a significant relation between D-Dimer levels and disease progression. Using the pre-structured proforma, patient’s clinical and laboratory data are collected and analysed after getting their consent. D-dimer values, course in hospital - oxygen requirement , drugs used with dosage, complications or adverse events that have occurred will all be recorded and statistical analysis will be done to correlate the two. The results of our study will help prompt triaging of the high risk patients and help rethink our treatment approach.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •RT-PCR of nasopharyngeal or oropharyngeal swab confirmed COVID-19 patients more than or equal to 18 years of age and either gender hospitalized for the illness.
排除标准
- •COVID-19 positive patients less than 18 years of age Patients on pre-hospitalization anti-coagulation Patients with cancer and prior thrombocytopenia or coagulopathy Patients having hospital stay less than 3 days.
结局指标
主要结局
Clinical recovery of the patient
时间窗: At baseline at 4 weeks
次要结局
- Complications during the hospital stay and immediately after discharge(At baseline at 4 weeks)
